_PRIVATE_LIMITED.webp)
Vivid Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-07-2024
- Paid Up Capital ₹ 0.14 M
as on 11-07-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 11-07-2024
- Revenue 23.79%
(FY 2017)
- Profit 419.10%
(FY 2017)
- Ebitda 22.30%
(FY 2017)
- Net Worth 152.72%
(FY 2017)
- Total Assets 19.31%
(FY 2017)
About Vivid Biotech (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.14 M.
The company currently has active open charges totaling ₹0.50 M.
Kanika Mehra and Suraj Mehra serve as directors at the Company.
- CIN/LLPIN
U74999DL1998PTC092262
- Company No.
092262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vivid Biotech (India) Private Limited offer?
Vivid Biotech (India) Private Limited offers a wide range of products and services, including Kitchen Cleaners, Vegetable and Fruit Wash, Organic Fertilizers and Manure, Humic Acid Powder and Liquid, Fertilizer, Bio Fertilizers, Micronutrient, Phosphate Rich Organic Manure (PROM), Seaweed Extract Fertilizers, Chemical Intermediates.
Who are the key members and board of directors at Vivid Biotech (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanika Mehra  | Director | 26-Sep-2016 | Current |
| Suraj Mehra | Director | 13-Feb-1998 | Current |
Financial Performance and Corporate Structure Insights of Vivid Biotech (India).
Vivid Biotech (India) Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 23.79% increase. The company also saw a substantial improvement in profitability, with a 419.1% increase in profit. The company's net worth Soared by an impressive increase of 152.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivid Biotech (India)?
In 2017, Vivid Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Patiala Creation Date: 18 Aug 1999 | ₹0.50 M | Open |
How Many Employees Work at Vivid Biotech (India)?
Unlock and access historical data on people associated with Vivid Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivid Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivid Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
